<PAGE>
As filed with the Securities and Exchange Commission on April 20, 1995
Registration No. 33-38347
______________________________________________________________________
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
____________
ELI LILLY AND COMPANY
(Exact name of registrant as specified in its charter)
____________
Indiana 35-0470950
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
Lilly Corporate Center
Indianapolis, Indiana 46285
317-276-2000
(Address, including zip code, and telephone number, including
area code of registrant's principal executive offices)
____________
REBECCA O. GOSS, Esq.
Vice President and General Counsel
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, Indiana 46285
317-276-2000
(Name, address, including zip code, and telephone number,
including area code of agent for services)
____________
Copies to:
Steven P. Lund, Esq. Keith L. Kearney, Esq.
Dewey Ballantine Davis Polk & Wardwell
1301 Avenue of the Americas 450 Lexington Avenue
New York, New York 10019-6092 New York, New York 10017
______________________________________________________________________
<PAGE>
<PAGE>
By filing this Post-Effective Amendment No. 1 to its Registration
Statement with the Securities and Exchange Commission (the "Commission"),
the Registrant is requesting the deregistration of $24,250,000 aggregate
principal amount of Debt Securities. Registrant previously registered
$500,000,000 aggregate principal amount of Debt Securities with the
Commission.<PAGE>
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on Form S-3 and has duly
caused this Amendment to the Registration Statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the City
of Indianapolis, State of Indiana, on April 17, 1995.
ELI LILLY AND COMPANY
By /s/ Randall L. Tobias
_________________________________________
(Randall L. Tobias, Chairman of the Board
and Chief Executive Officer)
Pursuant to the requirements of the Securities Act of 1933, this
Amendment to the Registration Statement has been signed by the
following persons in the capacities and on the date indicated.
Signature Title Date
/s/ Randall L. Tobias Chairman of the Board, April 17, 1995
___________________________________ Chief Executive
(Randall L. Tobias) Officer, and a
Director (principal
executive officer)
/s/ James M. Cornelius Vice President, Finance, April 17, 1995
___________________________________ Chief Financial
(James M. Cornelius) Officer, and a Director
(principal financial
officer)
/s/ Arnold C. Hanish Chief Accounting Officer April 17, 1995
___________________________________ (principal accounting
(Arnold C. Hanish) officer)
/s/ Steven C. Beering, M.D. Director April 17, 1995
___________________________________
(Steven C. Beering, M.D.)
Director April 17, 1995
___________________________________
(James W. Cozad)
/s/ Alfred G. Gilman, M.D., Ph.D. Director April 17, 1995
___________________________________
(Alfred G. Gilman, M.D., Ph.D.)
<PAGE>
<PAGE>
Signature Title Date
/s/ Karen N. Horn, Ph.D. Director April 17, 1995
________________________________________
(Karen N. Horn, Ph.D.)
/s/ J. Clayburn La Force, Jr., Ph.D. Director April 17, 1995
________________________________________
(J. Clayburn La Force, Jr., Ph.D.)
/s/ Kenneth L. Lay, Ph.D. Director April 17, 1995
________________________________________
(Kenneth L. Lay, Ph.D.)
/s/ Franklyn G. Prendergast, M.D., Ph.D. Director April 17, 1995
________________________________________
(Franklyn G. Prendergast, M.D., Ph.D.)
/s/ Kathi P. Seifert Director April 17, 1995
________________________________________
(Kathi P. Seifert)
/s/ Stephen A. Stitle Director April 17, 1995
________________________________________
(Stephen A. Stitle)
/s/ Sidney Taurel Director April 17, 1995
________________________________________
(Sidney Taurel)
/s/ August M. Watanabe, M.D. Director April 17, 1995
________________________________________
(August M. Watanabe, M.D.)
/s/ Alva O. Way Director April 17, 1995
________________________________________
(Alva O. Way)
/s/ Richard D. Wood Director April 17, 1995
________________________________________
(Richard D. Wood)
<PAGE>
<PAGE>
April 20, 1995
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Re: Eli Lilly and Company Post-Effective
Amendment No. 1 to Form S-3 Registration
Statement (Registration No. 33-38347)
________________________________________
Dear Sirs:
On behalf of Eli Lilly and Company (the "Company"),
transmitted herewith by electronic transmission under the EDGAR
system is Post-Effective Amendment No. 1 to the Registration
Statement on Form S-3 (Registration No. 33-38347) (the "Amendment").
By this Amendment, the Company is deregistering $24,250,000
aggregate principal amount of Debt Securities.
Should you have any questions in connection with this filing,
please call me collect at (212) 259-6746.
Very truly yours,
Joon S. Kim
Enclosures
